Fosfestrol

1A6 (anti-FGF19) is a humanized monoclonal antibody that specifically targets FGF19. 1A6 (anti-FGF19) has antitumoe activities and can used in the treatment of hepatocellular carcinoma (HCC).

1A6 (anti-FGF19) is a humanized monoclonal antibody that specifically targets FGF19. 1A6 (anti-FGF19) has antitumoe activities and can used in the treatment of hepatocellular carcinoma (HCC).

1A6 (anti-FGF19) is a humanized monoclonal antibody that specifically targets FGF19. 1A6 (anti-FGF19) has antitumoe activities and can used in the treatment of hepatocellular carcinoma (HCC).

AGAROSE, P.F.G.E.- 1KG

ALLO-2 is a potent drug-resistant Smoothened (Smo) mutant antagonist that inhibits Smo agonist Hh-Ag1.5-induced luciferase expression in TM3-Gli-Luc cells with IC 50 of 6 nMIC50&amp: Target:IC50: Smo.

One of the hallmarks of the early stages of apoptosis is the redistribution of membrane phospholipids such as phosphatidylserine and phosphatidylethanolamine from the inner to outer leaflet of the membrane bilayer where they are exposed on the cell

Annexin V- Alexa Fluor® 405 Apoptosis Assay

Annexin V- Alexa Fluor® 405 Apoptosis Assay

Annexin V- Alexa Fluor® 405 Apoptosis Assay

Annexin V- Alexa Fluor® 488 Apoptosis Assay

Annexin V- Alexa Fluor® 488 Apoptosis Assay

Annexin V- Alexa Fluor® 488 Apoptosis Assay